BIOCRYST PHARMACEUTICALS, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
BIOCRYST PHARMACEUTICALS, INC. (BCRX) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 18.95 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-05
- BIOCRYST PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 50.80M shares, a 58.85% increase year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 31.98M shares, a 30.03% decline year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 45.70M shares, a 17.70% decline year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-06-30 was 19.77M shares, a 14.38% decline year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 32.07M shares, a 40.99% decline from fiscal 2024.
- BIOCRYST PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 54.35M shares, a 14.33% increase from fiscal 2023.
- BIOCRYST PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 47.54M shares, a 15.55% decline from fiscal 2022.
- BIOCRYST PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 56.29M shares, a 216117.25% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 18.95M shares 10-Q · filed 2026-08-05 | |||||||
| 2026-03-31 | 50.80M shares 10-Q · filed 2026-05-06 | |||||||
| 2025-12-31 | 32.07M shares 10-K · filed 2026-02-26 | |||||||
| 2025-09-30 | 22.19M shares 10-Q · filed 2025-11-04 | |||||||
| 2025-06-30 | 22.04M shares 10-Q · filed 2026-08-05 | |||||||
| 2025-03-31 | 31.98M shares 10-Q · filed 2026-05-06 | |||||||
| 2024-12-31 | 54.35M shares 10-K · filed 2026-02-26 | |||||||
| 2024-09-30 | 44.44M shares 10-Q · filed 2025-11-04 | |||||||
| 2024-06-30 | 45.00M shares 10-Q · filed 2025-08-05 | |||||||
| 2024-03-31 | 45.70M shares 10-Q · filed 2025-05-06 | |||||||
| 2023-12-31 | 47.54M shares 10-K · filed 2026-02-26 | |||||||
| 2023-09-30 | 54.77M shares 10-Q · filed 2024-11-05 | |||||||
| 2023-06-30 | 19.77M shares 10-Q · filed 2023-08-07 | 55.21M shares 10-Q · filed 2024-08-06 | 20.95M shares 10-Q · filed 2023-08-07 | |||||
| 2023-03-31 | 55.53M shares 10-Q · filed 2024-05-07 | 21.64M shares 10-Q · filed 2023-05-08 | ||||||
| 2022-12-31 | 56.29M shares 10-K · filed 2024-02-27 | 25.60K shares 10-K · filed 2023-02-27 | ||||||
| 2022-09-30 | 26.24M shares 10-Q · filed 2022-11-04 | 50.43M shares 10-Q · filed 2023-11-08 | 25.92M shares 10-Q · filed 2022-11-04 | |||||
| 2022-06-30 | 23.09M shares 10-Q · filed 2023-08-07 | 25.88M shares 10-Q · filed 2023-08-07 | ||||||
| 2022-03-31 | 28.70M shares 10-Q · filed 2023-05-08 | |||||||
| 2021-12-31 | 26.03K shares 10-K · filed 2023-02-27 | |||||||
| 2021-09-30 | 28.47M shares 10-Q · filed 2022-11-04 | 26.13M shares 10-Q · filed 2022-11-04 | ||||||
| 2021-06-30 | 27.42M shares 10-Q · filed 2022-08-05 | 27.42K shares 10-Q · filed 2021-08-09 | 25.87M shares 10-Q · filed 2022-08-05 | 25.87K shares 10-Q · filed 2021-08-09 | ||||
| 2021-03-31 | 23.74M shares 10-Q · filed 2022-05-09 | 23.74K shares 10-Q · filed 2021-05-07 | ||||||
| 2020-12-31 | 14.96K shares 10-K · filed 2023-02-27 | |||||||
| 2020-09-30 | 16.54M shares 10-Q · filed 2021-11-04 | 14.15M shares 10-Q · filed 2021-11-04 | ||||||
| 2020-06-30 | 14.01K shares 10-Q · filed 2021-08-09 | 12.96K shares 10-Q · filed 2021-08-09 | 12.96M shares 10-Q · filed 2020-08-07 | |||||
| 2020-03-31 | 12.20K shares 10-Q · filed 2021-05-07 | 12.20M shares 10-Q · filed 2020-05-11 | ||||||
| 2019-12-31 | 2.81K shares 10-K · filed 2022-02-28 | 2.81M shares 10-K · filed 2020-03-13 | ||||||
| 2019-09-30 | 541.00K shares 10-Q · filed 2020-11-06 | 541.00 shares 10-Q · filed 2019-11-08 | 1.89M shares 10-Q · filed 2020-11-06 | 1.89K shares 10-Q · filed 2019-11-08 | ||||
| 2019-06-30 | 1.93K shares 10-Q · filed 2020-08-07 | 2.53M shares 10-Q · filed 2020-08-07 | 2.53K shares 10-Q · filed 2019-08-08 | |||||
| 2019-03-31 | 3.41M shares 10-Q · filed 2020-05-11 | |||||||
| 2018-12-31 | 2.27K shares 10-K · filed 2021-03-01 | 2.27M shares 10-K · filed 2019-03-14 | ||||||
| 2018-09-30 | 2.48K shares 10-Q · filed 2019-11-08 | 2.48M shares 10-Q · filed 2018-11-08 | 2.07K shares 10-Q · filed 2019-11-08 | 2.07M shares 10-Q · filed 2018-11-08 | ||||
| 2018-06-30 | 1.94K shares 10-Q · filed 2019-08-08 | 1.94M shares 10-Q · filed 2018-08-09 | 1.85K shares 10-Q · filed 2019-08-08 | 1.85M shares 10-Q · filed 2018-08-09 | ||||
| 2018-03-31 | 1.77M shares 10-Q · filed 2019-05-09 | |||||||
| 2017-12-31 | 2.07M shares 10-K · filed 2020-03-13 | |||||||
| 2017-09-30 | 2.00M shares 10-Q · filed 2018-11-08 | 2.52M shares 10-Q · filed 2018-11-08 | ||||||
| 2017-06-30 | 2.21M shares 10-Q · filed 2018-08-09 | 2.48M shares 10-Q · filed 2018-08-09 | ||||||
| 2017-03-31 | 2.76M shares 10-Q · filed 2018-05-09 | |||||||
| 2016-12-31 | 1.23M shares 10-K · filed 2019-03-14 | |||||||
| 2016-09-30 | 1.29M shares 10-Q · filed 2017-11-08 | 1.19M shares 10-Q · filed 2017-11-08 | ||||||
| 2016-06-30 | 885.00K shares 10-Q · filed 2017-08-08 | 1.09M shares 10-Q · filed 2017-08-08 | ||||||
| 2016-03-31 | 1.33M shares 10-Q · filed 2017-05-08 | |||||||
| 2015-12-31 | 3.52M shares 10-K · filed 2018-03-12 | |||||||
| 2015-09-30 | 3.82M shares 10-Q · filed 2016-11-08 | 3.67M shares 10-Q · filed 2016-11-08 | ||||||
| 2015-06-30 | 4.04M shares 10-Q · filed 2016-08-08 | |||||||
| 2015-03-31 | 3.53M shares 10-Q · filed 2016-05-09 | 3.46M shares 10-Q · filed 2015-05-08 | ||||||
| 2014-12-31 | 3.99M shares 10-K · filed 2017-02-27 | 5.28M shares 10-K · filed 2015-03-02 | ||||||
| 2014-09-30 | 4.24M shares 10-Q · filed 2015-11-06 | 5.60M shares 10-Q · filed 2014-11-07 | 3.99M shares 10-Q · filed 2015-11-06 | 5.29M shares 10-Q · filed 2014-11-07 | ||||
| 2014-06-30 | 3.69M shares 10-Q · filed 2015-08-07 | 5.04M shares 10-Q · filed 2014-08-08 | 3.85M shares 10-Q · filed 2015-08-07 | 5.12M shares 10-Q · filed 2014-08-08 | ||||
| 2014-03-31 | 5.21M shares 10-Q · filed 2015-05-08 | |||||||
| 2013-12-31 | 1.43M shares 10-K · filed 2016-02-26 | 2.11M shares 10-K · filed 2014-03-10 | ||||||
| 2013-09-30 | 2.78M shares 10-Q · filed 2014-11-07 | 1.73M shares 10-Q · filed 2014-11-07 | ||||||
| 2013-06-30 | 978.00K shares 10-Q · filed 2014-08-08 | 852.00K shares 10-Q · filed 2014-08-08 | ||||||
| 2013-03-31 | 681.00K shares 10-Q · filed 2014-05-09 | 7.05M shares 10-Q · filed 2013-05-09 | ||||||
| 2012-12-31 | 1.03M shares 10-K · filed 2015-03-02 | 6.17M shares 10-K · filed 2013-03-11 | ||||||
| 2012-09-30 | 1.21M shares 10-Q · filed 2013-11-08 | 1.16M shares 10-Q · filed 2013-11-08 | ||||||
| 2012-06-30 | 1.09M shares 10-Q · filed 2013-08-08 | 1.14M shares 10-Q · filed 2013-08-08 | ||||||
| 2012-03-31 | 5.99M shares 10-Q · filed 2013-05-09 | |||||||
| 2011-12-31 | 1.00M shares 10-K · filed 2014-03-10 | 5.68M shares 10-K · filed 2013-03-11 | ||||||
| 2010-12-31 | 4.04M shares 10-K · filed 2013-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |